<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">Score </span>
   <span class="font25">MetaSite </span>
   <span class="font24">breast </span>
   <span class="font19">cancer </span>
   <span class="font19">Recurrence </span>
   <span class="font18">recurrence </span>
   <span class="font17">vs. </span>
   <span class="font17">tumor </span>
   <span class="font16">(.) </span>
   <span class="font16">TMEM </span>
   <span class="font16">distant </span>
   <span class="font16">using </span>
   <span class="font15">clinical </span>
   <span class="font15">patients </span>
   <span class="font15">prognostic </span>
   <span class="font15">study </span>
   <span class="font15">association </span>
   <span class="font14">Cancer </span>
   <span class="font14">HR/HER- </span>
   <span class="font14">{border-style </span>
   <span class="font13">DRFI </span>
   <span class="font13">assay </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">RFI </span>
   <span class="font13">cells </span>
   <span class="font13">expression </span>
   <span class="font13">risk </span>
   <span class="font13">weighted </span>
   <span class="font12">(p = .) </span>
   <span class="font12">metastasis </span>
   <span class="font12">negative </span>
   <span class="font12">HER </span>
   <span class="font12">associated </span>
   <span class="font12">cohort </span>
   <span class="font12">higher </span>
   <span class="font12">used </span>
   <span class="font12">adjuvant </span>
   <span class="font12">early </span>
   <span class="font12">including </span>
   <span class="font12">time </span>
   <span class="font12">years </span>
   <span class="font12">Breast </span>
   <span class="font12">cell </span>
   <span class="font12">included </span>
   <span class="font12">information </span>
   <span class="font12">triple </span>
   <span class="font12">Clin. </span>
   <span class="font12">Score, </span>
   <span class="font12">Table </span>
   <span class="font12">analysis </span>
   <span class="font12">disease </span>
   <span class="font12">gene </span>
   <span class="font12">group </span>
   <span class="font12">high </span>
   <span class="font12">invasive </span>
   <span class="font12">models </span>
   <span class="font12">primary </span>
   <span class="font12">significant </span>
   <span class="font12">tertile </span>
   <span class="font12">trial </span>
   <span class="font11">Weighted </span>
   <span class="font11">continuous </span>
   <span class="font11">model </span>
   <span class="font11">receptor </span>
   <span class="font11">Oncol../JCO... </span>
   <span class="font11">[], </span>
   <span class="font11">cancer. </span>
   <span class="font11">chemotherapy </span>
   <span class="font11">empirical </span>
   <span class="font11">evaluated </span>
   <span class="font11">follow-up </span>
   <span class="font11">free </span>
   <span class="font11">hormone </span>
   <span class="font11">image </span>
   <span class="font11">interval </span>
   <span class="font11">macrophages </span>
   <span class="font11">nodal </span>
   <span class="font11">overall </span>
   <span class="font11">px; </span>
   <span class="font11">recurrences </span>
   <span class="font11">shown </span>
   <span class="font11">{font-family </span>
   <span class="font11">&amp;gt; </span>
   <span class="font11">(n = ) </span>
   <span class="font11">Central </span>
   <span class="font11">Score. </span>
   <span class="font11">biomarker </span>
   <span class="font11">cases </span>
   <span class="font11">categorical </span>
   <span class="font11">classical </span>
   <span class="font11">coefficient </span>
   <span class="font11">death </span>
   <span class="font11">font-size </span>
   <span class="font11">invasion </span>
   <span class="font11">mammary </span>
   <span class="font11">positive </span>
   <span class="font11">sample </span>
   <span class="font11">subtype </span>
   <span class="font11">(&amp;lt;, </span>
   <span class="font11">(MetaSite </span>
   <span class="font11">Fig. </span>
   <span class="font11">Inc. </span>
   <span class="font11">Mena </span>
   <span class="font11">MetaStat, </span>
   <span class="font11">Model </span>
   <span class="font11">Tumor </span>
   <span class="font11">axillary </span>
   <span class="font11">compared </span>
   <span class="font11">cutpoints </span>
   <span class="font11">defined </span>
   <span class="font11">definitions </span>
   <span class="font11">did </span>
   <span class="font11">direct </span>
   <span class="font11">double; </span>
   <span class="font11">estimated </span>
   <span class="font11">hazards </span>
   <span class="font11">human </span>
   <span class="font11">identification </span>
   <span class="font11">mouse </span>
   <span class="font11">p-value </span>
   <span class="font11">plus </span>
   <span class="font11">population-based </span>
   <span class="font11">provided </span>
   <span class="font11">provides </span>
   <span class="font11">recurrence. </span>
   <span class="font11">relapse </span>
   <span class="font11">results </span>
   <span class="font11">serve </span>
   <span class="font11">significantly </span>
   <span class="font11">size </span>
   <span class="font11">status </span>
   <span class="font11">structures </span>
   <span class="font11">studies </span>
   <span class="font11">treated </span>
   <span class="font11">validation </span>
   <span class="font11">women </span>
   <span class="font11">&amp;lt;. </span>
   <span class="font11">(Fig. </span>
   <span class="font11">(p = .). </span>
   <span class="font11">Breast™ </span>
   <span class="font11">Cell </span>
   <span class="font11">College </span>
   <span class="font11">Einstein </span>
   <span class="font11">HER-negative </span>
   <span class="font11">IHC </span>
   <span class="font11">Node </span>
   <span class="font11">TAILORx </span>
   <span class="font11">automated </span>
   <span class="font11">blood </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cancer, </span>
   <span class="font11">central </span>
   <span class="font11">characteristics </span>
   <span class="font11">clinicopathologic </span>
   <span class="font11">cohort, </span>
   <span class="font11">complementary </span>
   <span class="font11">early-stage </span>
   <span class="font11">endothelial </span>
   <span class="font11">evaluating </span>
   <span class="font11">evidence </span>
   <span class="font11">fully </span>
   <span class="font11">grade </span>
   <span class="font11">grade, </span>
   <span class="font11">images </span>
   <span class="font11">intravasation </span>
   <span class="font11">local </span>
   <span class="font11">marker </span>
   <span class="font11">material </span>
   <span class="font11">mid-range </span>
   <span class="font11">multiparameter </span>
   <span class="font11">potential </span>
   <span class="font11">previously </span>
   <span class="font11">proportional </span>
   <span class="font11">ratio </span>
   <span class="font11">recurrence, </span>
   <span class="font11">samples </span>
   <span class="font11">solid; </span>
   <span class="font11">specimens </span>
   <span class="font11">streaming </span>
   <span class="font11">test </span>
   <span class="font11">therapy </span>
   <span class="font11">time-varying </span>
   <span class="font11">use </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(DRFI) </span>
   <span class="font10">(including </span>
   <span class="font10">(p = .), </span>
   <span class="font10">.SparanoJAet </span>
   <span class="font10">Albert </span>
   <span class="font10">BCRR./bcr </span>
   <span class="font10">Breast™) </span>
   <span class="font10">CD-positive </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">ECOG </span>
   <span class="font10">Estimated </span>
   <span class="font10">Grade </span>
   <span class="font10">Medicine, </span>
   <span class="font10">Natl </span>
   <span class="font10">Oncotype </span>
   <span class="font10">R.G., </span>
   <span class="font10">Res.: </span>
   <span class="font10">Supplementary </span>
   <span class="font10">TMEM-associated </span>
   <span class="font10">analyses </span>
   <span class="font10">bold </span>
   <span class="font10">cancerJ. </span>
   <span class="font10">carcinoma </span>
   <span class="font10">cases, </span>
   <span class="font10">censored </span>
   <span class="font10">courier; </span>
   <span class="font10">described </span>
   <span class="font10">diagnostic </span>
   <span class="font10">doxorubicin </span>
   <span class="font10">effect </span>
   <span class="font10">em; </span>
   <span class="font10">entry </span>
   <span class="font10">enumeration </span>
   <span class="font10">groups </span>
   <span class="font10">hazard </span>
   <span class="font10">identified </span>
   <span class="font10">intermediate </span>
   <span class="font10">known </span>
   <span class="font10">laboratory </span>
   <span class="font10">low </span>
   <span class="font10">mean </span>
   <span class="font10">metastatic </span>
   <span class="font10">original </span>
   <span class="font10">p-values </span>
   <span class="font10">percent </span>
   <span class="font10">provide </span>
   <span class="font10">pt;} </span>
   <span class="font10">quantitative </span>
   <span class="font10">scores </span>
   <span class="font10">similar </span>
   <span class="font10">specific </span>
   <span class="font10">standard </span>
   <span class="font10">testing </span>
   <span class="font10">validity </span>
  </p>
 </body>
</html>
